Guggenheim Capital’s Forma Therapeutics Holdings, Inc. Common Stock FMTX Stock Holding History

Guggenheim Capital’s Portfolio FMTX Stock Details FMTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-14,053	Closed	-$280K	–	2042
2022 Q3	$280K	Buy	+14,053	New	+$185K	﹤0.01%	1684

Guggenheim Capital's FMTX Position: Q4 2022 in Review

Guggenheim Capital sold out of Forma Therapeutics Holdings, Inc. Common Stock (FMTX) in Q4 2022, closing a stake of 14,053 shares — an estimated $280K sold.

Guggenheim Capital first reported a position in FMTX in Q3 2022 and held it in 1 quarter. The position peaked at $280K in Q3 2022. 0 funds tracked by Wall St. Rank hold FMTX as of Q4 2022.

Guggenheim Capital reported no remaining Forma Therapeutics Holdings, Inc. Common Stock position as of Q4 2022 after selling out during the quarter.
Guggenheim Capital sold 14,053 Forma Therapeutics Holdings, Inc. Common Stock shares in Q4 2022, an estimated $280K.
Guggenheim Capital first reported a position in Forma Therapeutics Holdings, Inc. Common Stock in Q3 2022 and held it in 1 quarter.
Guggenheim Capital's Forma Therapeutics Holdings, Inc. Common Stock position peaked at $280K in Q3 2022.
0 funds tracked by Wall St. Rank held Forma Therapeutics Holdings, Inc. Common Stock as of Q4 2022.

Based on Guggenheim Capital's 13F filing for Q4 2022, filed 14 Feb 2023.